Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib + Tamoxifen in Metastatic Breast Cancer
NCT00229697Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2003
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of gefitinib in breast cancer, sponsored by AstraZeneca. Started Oct 2003; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00229697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00229697.